Evidence-led epilepsy resourceFor patients, families and health professionals

Understand epilepsy.
Choose treatment wisely.

EpilepsyWise brings diagnosis, first aid, daily-life guidance and clinical treatment into one place. Its central principle is simple: the treatment should not become a greater burden than the epilepsy it is meant to control.

NEW · INTERACTIVE LEARNING LAB

Follow the clues. Choose wisely.

Build a pathway from symptoms to epilepsy patterns, EEG and MRI, then medicine choice. Or test your reasoning with eight short cases.

Explore the learning lab
Flagship feature

LevWise

A deep, evidence-led examination of levetiracetam — not because the drug is “bad”, but because it shows what can go wrong when any medicine becomes a reflex choice.

Enter LevWise

LevWise is not against levetiracetam.

Levetiracetam is an important antiseizure medicine with legitimate and often valuable uses. The concern is reflex prescribing: using it as a default without enough attention to epilepsy type, behavioural vulnerability, comorbidities, alternatives and treatment burden.

The principle now extends to every drug

Don't replace one prescribing favourite with another. Compare mechanism, efficacy, half-life, interactions, adverse effects and the individual patient.

Open the complete medicine guide

The EpilepsyWise philosophy

Aim for the best achievable seizure control with the least possible adverse-effect burden, so that a person's life is disturbed as little as possible by either epilepsy or its treatment — including the possibility of returning to driving when seizure control and licensing standards permit.

Read our philosophy